Abstract
The aim of this cross-sectional retrospective study was to describe clinical and functional characteristics and the microbiological profile of an adult population with cystic fibrosis. The study was performed at the Pulmonary Diseases Service of the Hospital of the Medical School of the State University of Campinas. The charts of 54 adults (27 males, 27 females) with cystic fibrosis were reviewed. Demographic, clinical, and microbiological data were collected. Clinical and functional characteristics of patients with chronic Pseudomonas infection were compared with those without it. The mean age of the patients was 41.8 years and the mean sweat chloride concentration was 106.4 mEq/L. Forty-nine percent had chronic respiratory symptoms only after 18 years of age, and 85% reported chronic production of purulent sputum. Six percent had diarrhea or fat in stools, and no patient suffered from diabetes mellitus. Pseudomonas was present in 48%, and 73% of them had the mucoid strain. Others agents found were Staphylococcus aureus (28%), Hemophylus sp. (34%), Aspergillus sp. (22%), Stenotrophomonas maltophilia (9%), Acinetobacter sp. (7%), and Burkholderia cepacia (2%). Nontuberculous mycobacteria were found in sputum from 9 patients (11%); 34 patients (67%) had obstructive ventilatory defect; and 47% had obstruction and restriction. Concerning the groups with and without Pseudomonas colonization, only the values of sweat chloride were significantly higher in chronic colonized patients. Less severe phenotypes of cystic fibrosis may be found among patients previously diagnosed as having bronchiectasis. Chronic colonization with Pseudomonas aeruginosa in this study was not associated with worse clinical status but colonized patients did show significantly higher levels of chloride in sweat.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CF:
-
Cystic fibrosis
- CFTR:
-
Cystic fibrosis transmembrane conductance regulator
- COPD:
-
Chronic obstructive pulmonary disease
- FEV1 :
-
Forced expiratory volume in one second
- FVC:
-
Forced vital capacity
- SaO2 :
-
Oxygen saturation
References
Bandy V, Apicella MA, Mason E, et al. (2001) Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 164:2114–2119
Boucher RC (2004) Relationship of airway epithelial ion transport to chronic bronchitis. Proc Am Thorac Soc 1:66–70
Elborn JS, Shale DJ, Britton JR (1991) Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 46:881–885
Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918–951
Hansell DM (2001) Small airways diseases: detection and insights with computed tomography. Eur Respir J 17:1294–1313
Hart CA, Winstanley C (2002) Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Brit Med Bull 61:81–96
Hodson ME, Gallagher CG, Govan JRW (2002) A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 20:658–664
Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15(2):194–222
Noone PG, Leigh MW, Sannuti A, et al. (2004) Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 169:459–467
Pasteur MC, Helliwell SM, Houghton SJ, et al. (2000) An investigation into causative factors in patients with bronchiectasis. J Respir Crit Care Med 162:1277–1284
Patel IS, Vlahos I, Wilkinson TMA, et al. (2004) Bronchiectasis, exacerbation indices and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170:400–407
Pauwels RA, Builst AS, Calverley PMA, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Workshop Summary. Am J Respir Crit Care Med 163:1256–1276
Roberts HR, Wells AU, Milne DG, et al. (2000) Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 55:198–204
Rodman DM, Polis JM, Heltshe SL, et al. (2005) Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 171:621–626
Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement; Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:589–595
Sciurba FC (2004) Physiologic similarities and differences between COPD and asthma. Chest 126(2 Suppl):117S–124S
Wallace RJ, Glassroth J, Griffith DE, et al. (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156(Suppl):S1–S25
Widerman E, Millner L, Sexauer W, Fiel S (2000) Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years. Chest 118:427–433
Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D (2004) Cystic fibrosis adult care. Chest 125:1S–39S
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented in part at the 28th European Cystic Fibrosis Conference, Crete, Greece, 22–25 June 2005
Rights and permissions
About this article
Cite this article
Paschoal, I.A., de Oliveira Villalba, W., Bertuzzo, C.S. et al. Cystic Fibrosis in Adults. Lung 185, 81–87 (2007). https://doi.org/10.1007/s00408-006-2597-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-006-2597-0